Level Bio
0.379 SEK -0.26%Be the first to follow this company
Level Bio is active within medical technology. Today the business is focused on development of patented technology enabling the identification of viruses and bacteria. Products are sold under a number of trademarks as well as through own distribution to laboratories and research institutes. The largest business is found within the Nordic market. The head office is located in Nacka.
Revenue
26.1M
EBIT %
-37.28 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Nordic SME
LEVBIO
Daily low / high price
0.322 / 0.379
SEK
Market cap
24.03M SEK
Turnover
7.38K SEK
Volume
21K
Financial calendar
Extraordinary general meeting
2024-07-09
Interim report
2024-08-22
Interim report
2024-10-24
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Labkompaniet i Sverige AB | 31.4 % | 31.4 % |
Nordnet Pensionsförsäkring | 7.5 % | 7.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Level Bio AB: Aktieägare i Level Bio framlägger förslag till stämman om riktad nyemission till styrelseledamöter om totalt cirka 1,75 MSEK och föreslår val av ny styrelseledamot
Level Bio AB godkänns för avnotering från Spotlight Stock Market
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools